What is Xeomin?
Xeomin is an injectable that contains botulinum toxin type A and it is used to treat the vertical lines that appear between the brows. Movements in the facial muscles cause the area between the brows to contract, creating furrows and wrinkles. As time goes on, the wrinkles can become set.
The active ingredient in Xeomin, botulinum toxin type A, works on the nerve endings, blocking signals that trigger muscle movements. The muscles are temporarily unable to move or contract, reducing the appearance of frown lines. The injection was approved by the FDA in 2011 following a pair of studies that showed that Xeomin was more effective than placebos at reducing the frown lines.
The surgeons at the Glasgold Group perform Xeomin in New Jersey in the office setting. The injection typically takes about 20 minutes, and patients can return to their daily activities right away. An ice pack or topical anesthetic might be used to numb the injection area and reduce discomfort.
Typically, the results from Xeomin are visible after three or four days. 30 days after treatment, the results are most prominent. In most cases, results last for about three months, though they can last longer in some patients. Repeat treatments are possible, but should not be given more often than every three months.
Side effects can occur with Xeomin and can be mild or severe. Headache is common after the treatment. The treatment can also cause eye problems, including a drooping eyelid and double vision. If the botulinum toxin migrates to another area of the body, serious side effects can include trouble breathing or swallowing. Patients who develop these side effects need to see a doctor right away.
Discuss any concerns you have about side effects with your doctor before deciding to receive Xeomin. For more information, contact the Glasgold Group, the premier facial plastic surgery practice in New Jersey.